ES2147576T3 - Utilizacion del efaroxan y de sus derivados para la preparacion de un medicamento destinado al tratamiento de la enfermedad de parkinson. - Google Patents

Utilizacion del efaroxan y de sus derivados para la preparacion de un medicamento destinado al tratamiento de la enfermedad de parkinson.

Info

Publication number
ES2147576T3
ES2147576T3 ES94919712T ES94919712T ES2147576T3 ES 2147576 T3 ES2147576 T3 ES 2147576T3 ES 94919712 T ES94919712 T ES 94919712T ES 94919712 T ES94919712 T ES 94919712T ES 2147576 T3 ES2147576 T3 ES 2147576T3
Authority
ES
Spain
Prior art keywords
efaroxan
parkinson
disease
derivatives
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94919712T
Other languages
English (en)
Inventor
Francis Colpaert
Michael Briley
Thierry Imbert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Application granted granted Critical
Publication of ES2147576T3 publication Critical patent/ES2147576T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Abstract

LA PRESENTE INVENCION SE REFIERE A LA UTILIZACION DE EFAROXANO (MARCA REGISTRADA) Y A SUS DERIVADOS PARA LA PREPARACION DE UN MEDICAMENTO DESTINADO AL TRATAMIENTO DE LA ENFERMEDAD DE PARKINSON.
ES94919712T 1993-06-18 1994-06-15 Utilizacion del efaroxan y de sus derivados para la preparacion de un medicamento destinado al tratamiento de la enfermedad de parkinson. Expired - Lifetime ES2147576T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9307379A FR2706303B1 (fr) 1993-06-18 1993-06-18 Utilisation de l'Efaroxan et de ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson.

Publications (1)

Publication Number Publication Date
ES2147576T3 true ES2147576T3 (es) 2000-09-16

Family

ID=9448287

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94919712T Expired - Lifetime ES2147576T3 (es) 1993-06-18 1994-06-15 Utilizacion del efaroxan y de sus derivados para la preparacion de un medicamento destinado al tratamiento de la enfermedad de parkinson.

Country Status (15)

Country Link
US (1) US5948806A (es)
EP (1) EP0703781B1 (es)
JP (1) JP3394257B2 (es)
AT (1) ATE192650T1 (es)
AU (1) AU689783B2 (es)
CA (1) CA2165437A1 (es)
DE (1) DE69424415T2 (es)
DK (1) DK0703781T3 (es)
ES (1) ES2147576T3 (es)
FR (1) FR2706303B1 (es)
GR (1) GR3034062T3 (es)
NZ (1) NZ268039A (es)
PT (1) PT703781E (es)
WO (1) WO1995000145A1 (es)
ZA (1) ZA944281B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281207B1 (en) * 1999-09-15 2001-08-28 Reed Richter Treatment of movement disorders by administration of mirtazapine
FR2814368B1 (fr) * 2000-09-26 2004-05-07 Pf Medicament Preparation pharmaceutique a base d'oxans
US20040039041A1 (en) * 2000-11-14 2004-02-26 Antti Haapalinna Prevention of development of dyskinesias
US8188126B2 (en) 2002-05-16 2012-05-29 Pierre Fabre Medicament Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
WO2014172372A1 (en) 2013-04-15 2014-10-23 Northwestern University Treatment for dopaminergic disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ201219A (en) * 1981-07-28 1984-10-19 Reckitt & Colmann Prod Ltd Dihydrobenzofuranyl-2-imidazolines and pharmaceutical compositions
FR2669030B1 (fr) * 1990-11-14 1992-12-31 Adir Nouveaux derives d'imidazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5281607B1 (en) * 1992-10-08 1998-05-19 Univ New York Method of using alpha 2-antagonists for the treatment of neurodegenerative diseases

Also Published As

Publication number Publication date
AU7076494A (en) 1995-01-17
JPH09500375A (ja) 1997-01-14
WO1995000145A1 (fr) 1995-01-05
NZ268039A (en) 1999-06-29
EP0703781A1 (fr) 1996-04-03
US5948806A (en) 1999-09-07
FR2706303B1 (fr) 1995-09-08
DE69424415T2 (de) 2000-12-21
DE69424415D1 (de) 2000-06-15
EP0703781B1 (fr) 2000-05-10
ATE192650T1 (de) 2000-05-15
DK0703781T3 (da) 2000-10-02
GR3034062T3 (en) 2000-11-30
CA2165437A1 (fr) 1994-12-19
ZA944281B (en) 1995-02-10
PT703781E (pt) 2000-10-31
JP3394257B2 (ja) 2003-04-07
AU689783B2 (en) 1998-04-09
FR2706303A1 (fr) 1994-12-23

Similar Documents

Publication Publication Date Title
ATE205086T1 (de) Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit
MX9300014A (es) Nuevos derivados de 1,2,4-triaminobenceno y procedimiento para su elaboracion.
HUP9902105A2 (hu) Angiosztatikus dipeptideket tartalmazó gyógyászati készítmények és ezek alkalmazása
ITFI910071U1 (it) Piastra per osso per la porzione distale dell'omero.
ES2092890T3 (es) Aplicacion del riluzol en el tratamiento de la enfermedad de parkinson y de los sindromes de parkinson.
MX9305248A (es) Compuestos de diarilpiperazinoacetamida.
ES2144239T3 (es) Derivados de vitamina d con sustituyentes en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos.
NO302523B1 (no) Heterosykliske forbindelser, farmasöytiske preparater som omfatter dem, og anvendelse av forbindelsene for fremstilling av medikamenter
HUP9900819A1 (hu) Biciklusos aromás vegyületek, alkalmazásuk a humán- és állatgyógyászatban és a kozmetikában
IT1247509B (it) Composti di sintesi atti all'impiego nella terapia delle infezioni da rhinovirus
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
ES2135722T3 (es) 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina.
ES2147576T3 (es) Utilizacion del efaroxan y de sus derivados para la preparacion de un medicamento destinado al tratamiento de la enfermedad de parkinson.
AU655958B2 (en) Use of quisqualate-receptor antagonists for treating Parkinson's disease
MX9805065A (es) Nuevos derivados bi-aromaticos del dibenzofurano y su utilizacion en medicina humana o veterinaria asi como en cosmetica.
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
NZ303993A (en) Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
ES2118248T3 (es) Esteres y amidas de 9-cloro-prostaglandina y su empleo para preparar medicamentos.
ZA924128B (en) New combination preparations for treatment of Parkinson's disease.
ES2140544T3 (es) Utilizacion de efaroxan y de sus derivados para la fabricacion de medicamentos destinados al tratamiento de las enfermedades neurodegenerativas.
GR3015132T3 (en) Novel ureas and thioureas, preparation thereof and application in therapy.
GB9209599D0 (en) Novel therapy for the treatment of parkinsons disease
FR2818147B1 (fr) Nouvelle application therapeutique d'un derive de la thienyclyclohexylamine
ITGE910094A0 (it) Prodotto per la cura e la prevenzione del cancro e dell'aids
ZA921101B (en) Use of tetra: Hydro-thieno-pyrido-indole derivatives for the prepartion of a medicine for the treatment of skin disorders.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 703781

Country of ref document: ES